Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Breast Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6human papillomavirus vaccine, L1 type 16, 18 4Vaccines 3fluciclovine F-18 2pegylated granulocyte colony-stimulating factor 1halofantrine 1ferrous fumarate 1epoetin beta 1apatinib 1Tobacco Use Cessation Devices 1TachoSil 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Patient Navigation 1Papillomavirus Vaccines 1Mindfulness 1Indocyanine Green 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1Gonadal Steroid Hormones 1Gene Expression Profiling 1Engerix-B 1Early Intervention, Educational 1Counseling 1Cognitive Behavioral Therapy 1Cisplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Uterine Cervical Neoplasms × Patient Navigation × Clear all
NCT00613275 2016-06-15

Patient Navigation in the Safety Net:CONNECTeDD

Boston Medical Center

Phase 4 Completed
4,038 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡